Omics! Omics!

Judah Folkman's passing this week was a sad event. I got to hear the great man speak -- at Millennium's spectacular internal semina...

I'm probably going to stay up later than I should tonight watching the returns. Yep, I'm a junkie for the stuff -- it's just so...

If one thinks like a builder, it is not difficult to scan the prime biotech zone in Cambridge and see it full at some point. I remember bic...

My undergraduate days were full of laboratory work. I got involved in student research as an undergraduate, spent a xmemorable summer being...

Human society has long had a fascination with large human enterprises. Complex governmental systems, with ministers and sub-ministers, seem...

Hsien-Hsien is frequently asking 'What's in your DNA?', and a correspondent of mine recently pointed out that "it's in...

With the holiday season upon us, I break out my seasonal music. So it is only fitting while I ponder various versions of Greensleeves that ...

The Boston Globe had an article starting on the front page (briefly free, then will require $$) titled 'Critics blast slow progress on...

When the human genome was still terra incognito (or, at least our knowledge of the sequence was something like my view of the world sans my ...

Gene Logic today announced that Pfizer has filed a patent based on a Gene Logic drug repositioning effort. This would appear to be one of t...

I'm no fan of the local TV news broadcasts & therefore rarely catch them. So it was quite by accident that I caught a story last ni...

A significant challenge in pharmacology is the correct dosing of the drug. "The dose makes the poison" is an adage in toxicology,...

One of the journals I monitor by RSS is Nucleic Acids Research, and the usual steady flow of new items has become a torrent, mostly about d...

Marilyn vos Savant is a writer of a regular column in Parade magazine. These columns address many things, but often have interesting logic...

One component of many employment benefit packages in the U.S. (I don't know about other countries) is a Medical Flexible Spending Accoun...

A large lung cancer genomics study has been making a big splash. Using SNP microarrays to look for changes in the copy number of genes acr...

Tonight, of course, is Halloween, one of the many holidays which in the U.S. has a serious sweet tooth. After taking Version 2.0 around for...

Officially, I started this blog a year ago yesterday , with the first post about science coming the next day . At times, I wonder what posse...

One of the many attractions of the next generation sequencing techniques is that they eliminate the step of cloning in E.coli the DNA to be ...

G-protein coupled receptors, or GPCRs, are a key class of eukaryotic membrane receptors. Roughly 50% of all small molecule therapeutics tar...